Company Filing History:
10 out of 5,468 
1 out of 2 Years Active: 2013-2020
Title: Scott C. Weaver: Innovator in Viral Research
Introduction
Scott C. Weaver is a prominent inventor based in Galveston, TX (US), known for his significant contributions to the field of viral research. With a total of 10 patents, Weaver has made remarkable strides in developing innovative solutions to combat viral diseases.
Latest Patents
Among his latest patents is the invention of attenuated recombinant alphaviruses incapable of replicating in mosquitoes and their uses. This invention discloses an attenuated recombinant alphavirus that cannot replicate in mosquito cells or be transmitted by mosquito vectors. The alphaviruses may include, but are not limited to, Western Equine Encephalitis virus, Eastern equine encephalitis virus, Venezuelan equine encephalitis virus, or Chikungunya virus. The invention also outlines the method of generating such alphaviruses and their application as immunogenic compositions. Another notable patent involves recombinant Isfahan viral vectors, which are directed towards encoding a heterologous polynucleotide and methods of utilizing the same.
Career Highlights
Scott C. Weaver has worked with esteemed organizations such as the University of Texas System and Profectus Biosciences, Inc. His work has significantly impacted the understanding and treatment of viral infections.
Collaborations
Throughout his career, Weaver has collaborated with notable colleagues, including Ilya V. Frolov and Elena Frolova, contributing to advancements in viral research.
Conclusion
Scott C. Weaver's innovative work in the field of viral research has led to significant advancements in the development of vaccines and treatments for viral diseases. His contributions continue to shape the landscape of virology and public health.